Rii Share Discussion Threads

[lecks] 31/1/2005 10:16

I keep checking this 1, thanks

[ander] 31/1/2005 09:57

Lecks..yes my thoughts also. I will let you know if I get some clarification.
Which share thread/bb are you on most of the time ?

[lecks] 31/1/2005 09:49

Ander,

would be very interested to hear from you should you get a reply.

Can't really blame the person you are referring to - basically called it right all along - outcome at this point in time is a bit disapointing though.

I would feel more comfortable if the position of new shares was clarified i.e. will existing stock be converted to the equivalent amount of new stock at 0.75pence.

There must be something positive in this. Why go through a reverse takeover if there wasn't something solid to go on - not likely to know anything more until March time.

[ander] 31/1/2005 09:39

Lecks...I,like you,find it unclear about what will happen so I have sent an email to Insinger de Beaufort to see if they can clarify the situation. I am rather dissapointed that the person who was 'suggesting' everyone should buy these a couple of weeks ago has not had the decency to appear and give some explanation or answer your questions.

[lecks] 31/1/2005 09:06

cliffproud or anyone,

what will be the position of existing shares when new company is up and running - will they be converted to the equivalent amount of new shares at 0.75pence.

Also when they state that "they are seeking a waiver by the panel on takeovers and mergers of any requirement for a general offer" - does this mean that the placing for 400 million shares will be with institutions only - no public offer or offer to existing share holders?

[fatmansays] 28/1/2005 13:21

Not back trading a wet day and Mr.Weaver sells 1m shares for a lousy #40K or so. Feels you with confidence does'nt it.

[cliffproud] 28/1/2005 12:12

Hi
just catching up, and yes it all looks a bit confusing but from what I hear a deal with a major drugs company is on the cards DYOR, but I'm staying in and if I didn't already hold I would be buying.

[cityfarmer] 28/1/2005 09:53

Growbag,
Although many of your point above are true remember Glaxo was 'forced' to spin these drugs out as part of the regulatory approval to merge with Smithkline (competition grounds) and regards Chiroscience I remember them well and were a nice little earner for me! This is a risky stock which will return for more funds make no doubt about that but one worth a small punt I feel.

[growbag] 28/1/2005 09:36

No-one seems interested in actually researching the potential of the biopartners portfolio. And that is what ultimately will underpin the future
share price.

Neither compound has convincingly shown clinical effectiveness in humans, and both are a long way from doing so.

I'm not saying that this isn't worth a punt.

But its also worth bearing in mind that GS hold the patents to these compounds, and have declined to pursue development themselves. Bringing either the migraine or schizophrenia products to market will probably take at least two-three years, and require several cash injections and dilution.

Been there before with companies like Cortecs, Chiroscience etc ... if you can remember what happened to them.

[ander] 28/1/2005 08:42

Taken from Daily Mail today 28th January 2005. Geoff Foster column......

As expected, buyers filled their boots with RII when dealings were resumed on the Alternative Investment Market following its reverse takeover of BioPartners. More than 12m changed hands as the shares touched 5¼p before closing ⅝p dearer at 4½p.

[hard work] 28/1/2005 08:36

I'm having difficulty with this as well. 2b shares, current market value of £100m, early stage development.

400m shares at 0.75p - are they tied in? BioPartners shareholders holding 1.6b shares - are they tied in? What level of profit on their investment are they now showing?

[gismo] 27/1/2005 23:51

Well I must say that after reading this thread I am still totally confused. Buy now or wait that's the question....?

[lecks] 27/1/2005 23:45

Get real Dr Knowledge - do you really think that all existing shares will enter the new arrangment valued at 0.75p / share - if that was the case, we would already be at that level now

[dr knowledge] 27/1/2005 22:32

Lecks - but he/she has a point! - Our "arry" with the dark glasses touted this one for weeks - and, having a bit of respect for the man (dispite our infrequent disagreements), thought i'd take a good close look today!

Well I did, and I like the new company a lot (!!) - but the placing is absolutely and potentially lethal for private investors! Thats the problem with a few vocal brokers passing on tips to us - they don't always have our best interest at heart!

At the placing price - a steal, at this price - be careful!

[lecks] 27/1/2005 13:25

ydderF

who spends all his/her time starting threads that nobody posts on - that is an impressive list of threads - nearly as impressive as your math

[ydderf] 27/1/2005 13:08

Muppets why don't you sell your shares in the market now and stop being so silly? You can get 4p which is 5 x the price everyone buying the new shares will pay!

[ander] 27/1/2005 12:44

Note the change of adviser to Insinger de Beaufort.....the same adviser as Futuragene (FGN)!!

[basilrathbone] 27/1/2005 12:35

Don't you just love these placing that exclude the majority of existing shareholders.

[lecks] 27/1/2005 12:22

Well maybe they are confident that they have the the number 1 drug in this area and if it were to advance to stage iii trials, would they not be fairly sure that it was going to be commercially viable. If it safely negotiated this hurdle, £15m would be a small compared to it's earning potential - I can't see any other reason why a RII would buy into this deal unless they were convinced it had the potential.

[growbag] 27/1/2005 11:58

- but one of the drugs (tonabersat) isn't even in Phase II trials, let alone Phase III. Phase II and III trials are also very expensive to conduct. In addition, Biopartners would be expected to make milestone payments of £5m on the initiation of Phase III and a further £10m on initial revenue. Agreed that Migraine and Schizophrenia are big markets, but even if these compounds were eventually shown to have some clinical effectiveness (without killing the patients), there are other products about as well. The big pharmaceutical companies are also pursuing the same markets....

[moosley] 27/1/2005 11:46

The analyst value the two drugs at stage2 at 150-200 million pounds,that is without any other drugs they may have in the pipeline.

[lecks] 27/1/2005 11:32

cliffproud / harry

have you got a take on this?

[lecks] 27/1/2005 11:29

daz2004,

I must be as thick as you, or you must be as thick as me! I can't figure out the deal here either.

Our existing shares will probably be converted to the relevant amount of new shares at 0.75p - but what is the sweetner for existing shareholders? Will we be offered additional shares at a discount? I would have thought that there would have been some indication of why existing shareholders should buy into this deal, but the small boys will have no say in the matter, as there is a whole stack of "converted loan note guys" as well as existing directors / connected people who by far hold the bulk of current shares in issue.

But why would they buy into it?

They are buying the company for 1.613bln shares, so at 0.75p, just over 12mln pounds.

Quite a lot of shares floating about.

Aside from anything more sinister, there must be something pretty good in their research work, but would the market not know this - doen't appear at present to be any mad rush to buy these.

So much for the daily mail guy's prediction that "buyers would be all over these like a rash" - quite the contary.

Very confused